A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

Man’s best friend may become cancer’s worst enemy.

A multicancer early detection (MCED) test was developed and validated in the case-control Circulating Cell-free Genome Atlas (CCGA) study (ClinicalTrials.gov identifier: NCT02889978). Previous ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. Some companies now offer multi-cancer early detection ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a simple blood sample to detect pancreatic cancer at its earliest stages—when ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...

Prostate biopsies in Florida typically cost between $4,864 and $5,334 per procedure, representing a significant burden when a majority of procedures yield benign findings. If the study’s objectives ...

A new blood test can detect a precursor to liver disease, which can in turn be a harbinger of cancer. The hope is that the test could help prevent liver cancer before it occurs. The test uses a ...

Scientists have identified a blood-based protein signature that can predict lung cancer risk more than five years before diagnosis. Powered by AI and validated across global datasets, the breakthrough ...